Novozymes A/S (CPH:NSIS.B)

Novozymes Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	328.2	280	149.7	139.95	129.52	158.67
Cash & Short-Term Investments	328.2	280	149.7	139.95	129.52	158.67
Cash Growth	25.84%	87.04%	6.97%	8.06%	-18.37%	66.75%
Accounts Receivable	717.1	689.2	506.1	484.66	401.87	343.26
Other Receivables	169.8	174	77.1	72.33	108.27	90.28
Receivables	886.9	863.2	583.2	556.98	510.14	433.55
Inventory	799.6	720.6	486.7	511.27	402.41	317.2
Prepaid Expenses	-	-	-	23.39	-	-
Other Current Assets	37.2	15.6	49.9	10.76	10.09	19.08
Total Current Assets	2,052	1,879	1,270	1,242	1,052	928.49
Property, Plant & Equipment	2,834	2,968	1,654	1,623	1,370	1,291
Long-Term Investments	20.2	24	27.5	29.98	3.9	4.43
Goodwill	6,154	5,605	265	269.82	271.68	147.52
Other Intangible Assets	5,053	4,419	343	361.78	404.02	195.61
Long-Term Deferred Tax Assets	265.7	275	236.4	218.2	220.17	179.89
Other Long-Term Assets	22	24.7	14.2	16.67	9.28	8.2
Total Assets	16,401	15,196	3,809	3,762	3,331	2,756
Accounts Payable	302.1	423.1	216.9	251.27	200.4	147.78
Accrued Expenses	-	-	-	93.17	92.13	78.33
Current Portion of Long-Term Debt	347	266.4	432	392.43	287.68	148.59
Current Portion of Leases	-	-	-	16.54	16.41	18.27
Current Income Taxes Payable	126.9	60.9	24.6	43.83	65.36	45.14
Current Unearned Revenue	27.8	22.8	8.7	18.55	21.92	11.96
Other Current Liabilities	367.3	315.1	290.5	120.32	79.08	108.96
Total Current Liabilities	1,171	1,088	972.7	936.1	762.99	559.03
Long-Term Debt	2,975	1,530	612	486.54	494.94	435.83
Long-Term Leases	-	-	-	38.72	48.42	51.86
Long-Term Unearned Revenue	87	105.3	20.4	17.34	13.18	-
Long-Term Deferred Tax Liabilities	1,367	1,256	263.6	222.23	179.82	161.76
Other Long-Term Liabilities	58.4	39.7	15.1	148.29	190.04	36.41
Total Liabilities	5,658	4,020	1,884	1,849	1,689	1,245
Common Stock	125.6	125.6	75.4	75.56	75.85	76.58
Retained Earnings	11,037	11,032	1,846	1,756	1,520	1,513
Comprehensive Income & Other	-419.4	18	-45.4	28.64	-5.38	-80.61
Total Common Equity	10,743	11,176	1,876	1,860	1,591	1,509
Minority Interest	-	-	50	52.57	50.97	1.48
Shareholders' Equity	10,743	11,176	1,926	1,913	1,642	1,511
Total Liabilities & Equity	16,401	15,196	3,809	3,762	3,331	2,756
Total Debt	3,322	1,797	1,044	934.22	847.45	654.55
Net Cash (Debt)	-2,994	-1,517	-894.3	-794.27	-717.93	-495.88
Net Cash Per Share	-10.56	-5.46	-3.22	-2.85	-2.56	-1.76
Filing Date Shares Outstanding	465.6	277.9	464.62	276.6	277.11	279.33
Total Common Shares Outstanding	465.6	277.9	277.32	276.6	277.11	279.33
Working Capital	880.8	791.1	296.8	306.25	289.16	369.46
Book Value Per Share	23.07	40.22	6.76	6.73	5.74	5.40
Tangible Book Value	-464.3	1,152	1,268	1,229	914.97	1,166
Tangible Book Value Per Share	-1.00	4.14	4.57	4.44	3.30	4.17
Land	-	-	-	1,037	1,016	938.56
Machinery	-	-	-	2,049	1,971	1,798
Construction In Progress	-	-	-	389.34	117.82	91.63

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.